InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,867.60
(
-0.80%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.31
(
0.10%
)
Bitcoin
64,181.04
(
-0.16%
)
Post# of 175
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

gfp927z

Send PM Follow Ignore
Followers 84
Posts 32166
Boards Moderated 85
Alias Born 03/22/2005

gfp927z

Re: None

Sunday, 08/09/2015 8:10:11 PM

Sunday, August 09, 2015 8:10:11 PM

Post# of 175
>>> Macrocure Ltd., a biotechnology company, focuses on developing, manufacturing, and commercializing novel cell therapy products for the treatment of chronic and other hard-to-heal wounds in Israel. Its lead cell-based biological product includes CureXcell, which is in two Phase III clinical trials for the treatment of hard-to-heal diabetic foot ulcers and hard-to-heal venous leg ulcers. Macrocure Ltd. was founded in 2008 and is headquartered in Petach Tikva, Israel. <<<
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up